Insys Therapeutics Inc., of Phoenix, said its collaboration with the Center for Medicinal Cannabis Research at the University of California San Diego School of Medicine has added a third study, aimed at evaluating pharmacological effects of cannabidiol oral solution on anxiety associated with anorexia nervosa in adults. The IND is on track for filing in the fourth quarter.